Literature DB >> 20517611

Chylous ascites: a rare complication of thoracic duct embolization for chylothorax.

Ron C Gaba1, Charles A Owens, James T Bui, Tami C Carrillo, M Grace Knuttinen.   

Abstract

Thoracic duct embolization represents a safe and effective method to treat postsurgical chylothorax. Complications of this procedure are rare despite transabdominal puncture of lymphatic channels for thoracic duct access, and chylous ascites is unreported. Herein, we describe a case of chylous ascites formation after lymphatic puncture and attempted cannulation. Our management approach is also discussed.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20517611     DOI： 10.1007/s00270-010-9900-4

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN： 0174-1551            Impact factor:   2.740


  5 in total

Review 1.  Treatment options in patients with chylothorax.

Authors:  Hans H Schild; Christian P Strassburg; Armin Welz; Jörg Kalff
Journal:  Dtsch Arztebl Int       Date:  2013-11-29       Impact factor: 5.594

2.  A novel technique in the treatment of retroperitoneal lymphatic leakage: direct percutaneous embolization through the leakage pouch.

Authors:  Hasan Dinç; Şükrü Oğuz; Ahmet Sarı
Journal:  Diagn Interv Radiol       Date:  2015 Sep-Oct       Impact factor: 2.630

3.  Two cases of pelvic lymphocele after prostatectomy and dissection of obturator lymph nodes successfully treated by interventional radiology.

Authors:  Yuki Oda; Nobuo Ohyama; Masahiro Hashimura; Shinsaku Maeda; Shunta Hori; Kiyohide Fujimoto
Journal:  IJU Case Rep       Date:  2021-06-28

4.  Cholecystitis-an uncommon complication following thoracic duct embolization for chylothorax: A case report.

Authors:  Le Viet Dung; Ma Mai Hien; Thieu-Thi Tra My; Doan Tien Luu; Le Tuan Linh; Nguyen Minh Duc
Journal:  World J Clin Cases       Date:  2022-08-26       Impact factor: 1.534

5.  Unconventional management of chyloascites after laparoscopic Nissen fundoplication.

Authors:  Paul F Hwang; Karen A Ospina; Earl H Lee; Scott R Rehring
Journal:  JSLS       Date:  2012 Apr-Jun       Impact factor: 2.172
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.